T11-036 Tohoku University’s Invention Anti-cancer drug with HDAC and PI3K inhibitory activity low molecular weight compound with anti-cancer activity for nano-molarity

First Page		Document Content
Date: 2012-09-27 22:51:13 Prodrugs Drug discovery Phosphoinositide 3-kinase inhibitor Histone deacetylase Romidepsin Phosphoinositide 3-kinase LY294002 Wortmannin Medicine Pharmacology Depsipeptides		T11-036 Tohoku University’s Invention Anti-cancer drug with HDAC and PI3K inhibitory activity low molecular weight compound with anti-cancer activity for nano-molarity Add to Reading List Source URL: www.t-technoarch.co.jp Download Document from Source Website File Size: 175,62 KB Share Document on Facebook

	CMTF005 - Food is Medicine - Checklist_Debranded DocID: 1xVMk - View Document
	Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin† DocID: 1xVge - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_with bleed DocID: 1xUza - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_edited DocID: 1xTtU - View Document
	PDF Document DocID: 1xSqy - View Document